Supreme Court To Hear Major Case On The Abortion Pill
The Supreme Court will hear on Tuesday a major challenge to the abortion pill brought by doctors and medical associations.
In FDA v. Alliance for Hippocratic Medicine, one of two cases on abortion the Supreme Court will hear this term since overturning Roe v. Wade in 2022, the justices will consider the U.S. Food and Drug Administration’s (FDA) decision to roll back safety regulations for the chemical abortion drug mifepristone. Doctors who sued the FDA contend that the removal of safety standards once deemed “essential” makes it more likely women will require medical treatment, forcing OB-GYNs and emergency room doctors to address the “serious complications caused by these drugs.”
“My moral and ethical obligation to my patients is to promote human life and health,” Dr. Ingrid Skop, a member of the plaintiff organization American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), wrote in a declaration. “But the FDA’s actions may force me to end the life of a human being in the womb for no medical reason.”
In 2021, the FDA allowed distribution of mifepristone through the mail and removed the requirement for an initial in-person visit. Earlier, in 2016, the agency removed many of the safeguards implemented when the pill was approved in 2000, allowing it to be used through ten weeks of pregnancy, rather than seven. (Read more from “Supreme Court To Hear Major Case On The Abortion Pill” HERE)
